DVL1 and cancer: Wnt signaling can promote Dsh/Dvl accumulation [40], and Dvl overexpression can mimic activation of the Wnt/β-catenin signaling axis [41], suggesting that Dvl hyperactivity, like β-catenin stabilization due to mutation, could be a primary cause of elevated Wnt signaling in cancer.